Announce Date | 05/05/2025 |
EPS Normalized Actual | $0.01 (Miss by $-0.17) |
EPS GAAP Actual | $0.01 (Miss by $-0.17) |
Revenue Actual | $0.297591B |
Revenue Surprise | Beat by $297.591M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.05209 |
EPS GAAP Estimate | $1.05209 |
Revenue Estimate | $0.319071667B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.25 | 6.09 | 2.07625 | 2.43441 | 1 |
Dec 2027 | 5.14 | 2.67 | 4.19464 | 5.50833 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.01 | -0.99313 | 0.297591B | 35.26% | -14.95M |
FQ4 2024 (Dec 2024) | 0.13 | -0.43072 | 0.271338B | 47.98% | -65.3M |
FQ3 2024 (Sep 2024) | 0.0357 | -1.50571 | 0.304434B | 48.23% | -59.59M |
FQ2 2024 (Jun 2024) | 0.13 | 0.13 | 0.287518B | 100% | 287.52M |
FQ4 2020 (Dec 2020) | -0.021 | -0.021 | 0.02632B | 100% | 26.32M |
FQ1 2021 (Mar 2021) | 0 | 0 | 0.031832B | 100% | 31.83M |
FQ2 2021 (Jun 2021) | 0 | 0 | 0.044427B | 100% | 44.43M |
FQ3 2021 (Sep 2021) | 0.0125 | 0.0125 | 0.043299B | 100% | 43.3M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
1.05209
Consensus Revenue Estimates
0.319071667B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.29 | -- | 1.20815 | 1.35735 | 1 |
FQ3 2027 (Sep 2027) | 1.29 | -- | 0.84748 | 1.49007 | 2 |
FQ2 2027 (Jun 2027) | 1.29 | -- | 0.84748 | 1.49007 | 2 |
FQ1 2027 (Mar 2027) | 1.29 | -- | 0.84748 | 1.49007 | 2 |
FQ4 2026 (Dec 2026) | 0.86004 | -- | 0.80547 | 0.90494 | 1 |
FQ3 2026 (Sep 2026) | 1.29 | -- | 0.84748 | 1.49007 | 3 |
FQ2 2026 (Jun 2026) | 1.29 | -- | 0.84748 | 1.49007 | 3 |
FQ1 2026 (Mar 2026) | 1.27 | 99.21 | 0.83434 | 1.46697 | 3 |
FQ4 2025 (Dec 2025) | 0.87772 | 85.19 | 0.82203 | 0.92355 | 2 |
FQ3 2025 (Sep 2025) | 1.05209 | 96.61 | 0.69118 | 1.21527 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.27B | -- | 0.26B | 0.28B | 2 |
FQ3 2027 (Sep 2027) | 0.27B | -- | 0.2B | 0.3B | 2 |
FQ2 2027 (Jun 2027) | 0.27B | -- | 0.2B | 0.3B | 2 |
FQ1 2027 (Mar 2027) | 0.27B | -- | 0.2B | 0.3B | 2 |
FQ4 2026 (Dec 2026) | 0.33B | -- | 0.31B | 0.34B | 2 |
FQ3 2026 (Sep 2026) | 0.27B | -- | 0.2B | 0.3B | 2 |
FQ2 2026 (Jun 2026) | 0.27B | -- | 0.2B | 0.3B | 2 |
FQ1 2026 (Mar 2026) | 0.27B | -10.63 | 0.2B | 0.3B | 2 |
FQ4 2025 (Dec 2025) | 0.34B | 20.02 | 0.32B | 0.35B | 1 |
FQ3 2025 (Sep 2025) | 0.32B | 4.59 | 0.23B | 0.36B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.00313 | 0.01 | -0.99313 | -9931.3% |
FQ4 2024 (Dec 2024) | 0.56072 | 0.13 | -0.43072 | -331.32% |
FQ3 2024 (Sep 2024) | 1.54141 | 0.0357 | -1.50571 | -4217.68% |
FQ2 2024 (Jun 2024) | 0.13 | 0.13 | 100% | |
FQ4 2020 (Dec 2020) | -0.021 | -0.021 | 100% | |
FQ1 2021 (Mar 2021) | 0 | 0 | NAN% | |
FQ2 2021 (Jun 2021) | 0 | 0 | NAN% | |
FQ3 2021 (Sep 2021) | 0.0125 | 0.0125 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.31B | $0.3B | $-14.95M | -5.02% |
FQ4 2024 (Dec 2024) | $0.34B | $0.27B | $-65.3M | -24.07% |
FQ3 2024 (Sep 2024) | $0.36B | $0.3B | $-59.59M | -19.57% |
FQ2 2024 (Jun 2024) | $0B | $0.29B | $287.52M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.03B | $26.32M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.03B | $31.83M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.04B | $44.43M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.04B | $43.3M | 100% |